Marina de Cos

MD, MSCR. Nephrologist 🇪🇸. Postdoctoral fellow at Campbell Lab (@ISMMSkidney) 🇺🇸. @GlomCon Fellow 2020. Be an enthusiast in life, lukewarm is no good.

[Mónica Furlano MD, PhD @m_furlano]

🧬1º Máster en Enfermedades Renales Hereditarias🧬

📚La medicina avanza y la formación especializada marca la diferencia.

🌟Un programa innovador diseñado para profundizar en el diagnóstico, manejo y abordaje integral de las patologías renales de origen genético🧬#GTERH 👇🏻

[JAMA @JAMA_current]

💬 Viewpoint: Physician well-being is maximized when comfort-based supports and opportunities for meaningful work are integrated, creating systems that sustain both engagement and purpose.

https://t.co/QdbDvNDLOi

[Katalin Susztak @KSusztak]

Here are 5 clinical advances from 2025 in kidney and cardiorenal medicine that clinicians across specialties should know before the year ends. These findings influence how we prevent and treat common, high-risk conditions. #MedTwitter #Nephrology

[Graham Abra, MD @GrahamAbra]

@HomeHemodialys1 @kidney_boy Agreed on more frequent dialysis. Note PISCES is ~5x the size of FHN Daily.

[Hans-Joachim Anders @hjanders_hans]

Everything you need to know about podocyte disorders @DiseasePrimers

@PRomagnani, @Tobias_B_Huber, @AstridWeins, @sydney_tang

https://t.co/E6X3sReqYH

[Marina de Cos @marinadecos]

Este sábado hablaré de podocitopatías autoinmunes en @GlomConILA. Una oportunidad para quien quiera ponerse al día con todas (o muchas) de las recientes novedades!! 🤓🔬

Gracias @senjoven por la invitación! 🥰

[GlomCon Ibero-LatinoAmérica @GlomConILA]

🚨No te pierdas este sábado el seminario:

☞ Anticuerpos emergentes en podocitopatías: del laboratorio a la práctica clínica

🗓️ 13/Dic/25
🕘 9 am CDMX
🗣️ Marina de Cos 🇪🇸🇺🇸

En colaboración con: JovSEN 🇪🇸

Zoom ID: 863 6358 3637
Pass: 343 190

#GlomConILA #GlomConAmor

[Hans-Joachim Anders @hjanders_hans]

Now out in @JASN_News
@StefanieSteige6 @PRomagnani

How to Cure Autoimmune GN and podocytopathies

🧐 All autoimmune kidney diseases, no matter what histotype or clinical presentation, benefit from a clone-directed immunotherapy.
▶️https://t.co/RBPMC9vLNx

[Paola Romagnani @PRomagnani]

It started by chance: in our all-women lab, only urine from 2 pregnant colleagues grew renal progenitors. Why? After 10 yrs, the answer is now in Science. Grateful to our brilliant first author @CarolinaConte5 from @UNI_FIRENZE who led the way! 👏 https://t.co/P2ATMuUCa6

[Pierpaolo Di Nicolò @PierpaDiNick]

#POCUS for trainees
Another extremely high degree renal artery stenosis😱

[Milagros Flores @dra_miliflores]

IgAN treatment dilemma: Proteinuria 📉 and eGFR stabilization are key, but is it time to consider other surrogates? 🤔 2025 @GlomCon @BradRovin 🎉

[Rosana Ferrero 📈📊🙌 @RosanaFerrero]

🎯 ¿CUÁNTO ES SUFICIENTE? El tamaño de muestra ideal 🚀
📉 Demasiado pequeño: Podrías pasar por alto un efecto importante.
💸 Demasiado grande: ¡Desperdicias recursos y esfuerzo!
🏆 El tamaño justo: Como en Ricitos de oro, detectar efectos relevantes sin malgastar recursos.

🧵

[Jesús Terrés @nadaimporta]

Abrazar.

[Emilie Cornec-Le Gall @ecorneclegall]

🚨 Dear all, do not miss this new KDIGO webinar series on NephroGenetics 🧬 ! Please do not hesitate to share, including amongst our younger colleagues @ERAkidney @com_SFNDT @FiliereORKiD @CJNephro @ynptweets @SNINephrologie

[Lori O'Brien @l_obrien_lab]

For all those interested in vascularizing organoids, check out this great paper from Maggiore et al on their inducible vascularized kidney organoid model and my accompanying commentary!
https://t.co/IJuE031oNh

https://t.co/X2amvyDlyU

[Marina de Cos @marinadecos]

@Nefrontera @JoseIbeas1 Congrats Sol!

[Scholarship for PhD @ScholarshipfPhd]

Evaluating Your Research Proposal

[Marina de Cos @marinadecos]

@JustinaLRay @kirkcampbell Thanks so much @JustinaLRay!! The best bench buddy I could have ever imagined!🫂

[Cristina Popa 🦋 @NephroSeeker]

Unedited love song for the kidneys during #nephjc party #kidneywk

All the applause go to @Maximal_Change

[Gbadegesin Lab @GbadegesinLab]

APOL1 variants and CKD in West Africa. One risk variant associated with FSGS and CKD. The story is getting more complex!! A call to sustain the momentum of cutting edge studies on APOL1 KD @OpeyemiOlabisi8 @KSusztak @SannaCherchiLab @kidneyomicsamps 🙏🏽